Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
August 7, 1992
Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor
M D Ennis, M E Baze, M W Smith, et al.
European Journal of Pharmacology
|
December 12, 1996
Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype
M F Piercey, M W Moon, V H Sethy, et al.
Journal of Medicinal Chemistry
|
March 19, 1993
Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist
R B McCall, A G Romero, M J Bienkowski, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds
M W Moon, J K Morris, R F Heier, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1994
Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist
M F Piercey, A H Tang, R A Lahti, et al.
Biological Psychiatry
|
May 17, 2000
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
E H Wong, M S Sonders, S G Amara, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
August 7, 1992
Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor
M D Ennis, M E Baze, M W Smith, et al.
European Journal of Pharmacology
|
December 12, 1996
Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype
M F Piercey, M W Moon, V H Sethy, et al.
Journal of Medicinal Chemistry
|
March 19, 1993
Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist
R B McCall, A G Romero, M J Bienkowski, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds
M W Moon, J K Morris, R F Heier, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1994
Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist
M F Piercey, A H Tang, R A Lahti, et al.
Biological Psychiatry
|
May 17, 2000
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
E H Wong, M S Sonders, S G Amara, et al.
Page
of 9